Investor Relations

Press Releases

All Releases
View Summary OPKO Announces Second Quarter Operating and Financial Results
Aug 11, 2014
PDF 25.6 KB
View Summary Rayaldee Phase 3 Trial Meets Primary Endpoints
Aug 11, 2014
PDF 16.2 KB
View Summary OPKO Submits IND for Rayaldee™ as Adjunctive Cancer Therapy
Aug 7, 2014
PDF 14.7 KB
View Summary OPKO to Announce Top Line RAYALDEE Results and Second Quarter 2014 Financial Results on August 11, 2014
Aug 7, 2014
PDF 11.2 KB
View Summary OPKO Granted Patent from US Patent & Trademark Office for RAYALDEE
Jul 22, 2014
PDF 12.4 KB
View Summary OPKO's Long-Acting Clotting Factor VIIa-CTP Receives Positive Opinion For Three Orphan Drug Designations in Europe
Jul 9, 2014
PDF 11.9 KB
View Summary OPKO Granted Patent from European Patent Office for Lagova™
Jun 27, 2014
PDF 10.5 KB
View Summary Strong Data from Lagova™ Phase II Clinical Study Presented during Webcast
Jun 25, 2014
PDF 14.3 KB
View Summary OPKO Announces Positive Interim Six-Month Lagova™ (hGH-CTP) Phase 2 Data in Pediatric Growth Hormone Deficiency Disorder
Jun 23, 2014
PDF 15.9 KB
View Summary OPKO to Hold Conference Call to Discuss Six Month Data from Phase 2 hGH-CTP Trial
Jun 19, 2014
PDF 14.1 KB
View Summary OPKO Health to Present at the Jefferies 2014 Global Healthcare Conference
May 28, 2014
PDF 8.4 KB
View Summary OPKO Completes Acquisition of Inspiro Medical Ltd.
May 22, 2014
PDF 10.3 KB
View Summary Data Supporting Once-Weekly Dosing of hGH-CTP in Growth Hormone Deficient Pediatric Population to Be Presented at the 2014 ICE/ENDO Meeting
May 20, 2014
PDF 12.0 KB
View Summary OPKO Presents 4Kscore™ Test Clinical Study at the American Urological Association Plenary Session
May 19, 2014
PDF 56.9 KB
View Summary Senesco Completes Acquisition of Fabrus, An OPKO Portfolio Company
May 19, 2014
PDF 11.7 KB
View Summary OPKO Licensee TESARO Announces Successful Achievement of Primary and All Secondary Endpoints in Third and Final Phase 3 Trial of Rolapitant
May 12, 2014
PDF 12.8 KB
View Summary OPKO Announces First Quarter Operating Results
May 9, 2014
PDF 21.2 KB
View Summary OPKO Announces Dismissal of PROLOR Biotech, Inc. Class Action Lawsuit
May 8, 2014
PDF 8.7 KB
View Summary OPKO Creates Global Supply Chain Structure
May 7, 2014
PDF 9.8 KB
View Summary OPKO Completes Patient Enrollment in Third Phase 3 Trial of RAYALDEE™
May 6, 2014
PDF 13.2 KB
Showing 1-20 of 182 Page: 1 2 3 4 5 ... 10  Next 20